Literature DB >> 10830640

The significance of a patent foramen ovale.

T O Cheng.   

Abstract

Mesh:

Year:  2000        PMID: 10830640      PMCID: PMC101035     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


× No keyword cloud information.
  11 in total

1.  Pulmonary embolism, patent foramen ovale and paradoxical embolism.

Authors:  T O Cheg
Journal:  J Cardiovasc Surg (Torino)       Date:  1999-10       Impact factor: 1.888

2.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  T O Cheng
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

3.  Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management.

Authors:  T O Cheng
Journal:  Catheter Cardiovasc Interv       Date:  1999-05       Impact factor: 2.692

4.  Hypoxia due to patent foramen ovale in the absence of pulmonary hypertension.

Authors:  R Maraj; O Ahmed; M Fraifeld; L E Jacobs; S Yazdanfar; M N Kotler
Journal:  Tex Heart Inst J       Date:  1999

5.  Paradoxic embolism.

Authors:  T O Cheng
Journal:  Am Heart J       Date:  1996-06       Impact factor: 4.749

6.  Impending paradoxical embolism.

Authors:  T O Cheng
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

7.  Paradoxical embolism. A diagnostic challenge and its detection during life.

Authors:  T O Cheng
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

8.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Authors:  P T Hagen; D G Scholz; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

9.  Persistent Eustachian valve causing severe cyanosis in atrial septal defect with normal right heart pressures.

Authors:  T Bashour; S Kabbani; M Saalouke; T O Cheng
Journal:  Angiology       Date:  1983-02       Impact factor: 3.619

10.  Echocardiography and paradoxical embolism.

Authors:  T O Cheng
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.